agilon health (NYSE:AGL) Price Target Lowered to $2.00 at Stifel Nicolaus

agilon health (NYSE:AGL) had its price objective reduced by Stifel Nicolaus from $7.00 to $2.00 in a research note published on Tuesday,Benzinga reports. They currently have a hold rating on the stock.

A number of other equities analysts have also issued reports on AGL. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 target price on shares of agilon health in a research report on Wednesday, August 7th. TD Cowen decreased their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a research note on Wednesday, October 2nd. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday. Finally, Barclays cut their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $7.03.

agilon health Stock Down 13.7 %

AGL opened at $1.87 on Tuesday. agilon health has a twelve month low of $1.80 and a twelve month high of $13.76. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The business has a 50 day moving average price of $3.22 and a 200 day moving average price of $4.95. The firm has a market cap of $767.41 million, a P/E ratio of -1.98 and a beta of 0.60.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. During the same quarter last year, the company earned ($0.06) earnings per share. Research analysts forecast that agilon health will post -0.32 EPS for the current year.

Insider Activity

In other news, CEO Steven Sell purchased 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. The trade was a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Algert Global LLC grew its stake in shares of agilon health by 80.2% during the third quarter. Algert Global LLC now owns 184,530 shares of the company’s stock worth $725,000 after purchasing an additional 82,123 shares during the period. Citigroup Inc. increased its stake in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the last quarter. Intech Investment Management LLC acquired a new stake in shares of agilon health in the 3rd quarter valued at approximately $228,000. Simplify Asset Management Inc. boosted its stake in agilon health by 67.5% during the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company’s stock worth $663,000 after acquiring an additional 67,968 shares during the last quarter. Finally, Aigen Investment Management LP bought a new position in agilon health during the 3rd quarter worth approximately $79,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.